Search Results - "Hurley, Michael J"

Refine Results
  1. 1

    Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson’s Disease: Therapeutic Rationale and Current Status by Swart, Tara, Hurley, Michael J.

    Published in CNS drugs (01-12-2016)
    “…Parkinson’s disease is a disabling hypokinetic neurological movement disorder in which the aetiology is unknown in the majority of cases. Current…”
    Get full text
    Journal Article
  2. 2

    Altered Gut Microbiota in a Fragile X Syndrome Mouse Model by Altimiras, Francisco, Garcia, José Antonio, Palacios-García, Ismael, Hurley, Michael J., Deacon, Robert, González, Bernardo, Cogram, Patricia

    Published in Frontiers in neuroscience (26-05-2021)
    “…The human gut microbiome is the ecosystem of microorganisms that live in the human digestive system. Several studies have related gut microbiome variants to…”
    Get full text
    Journal Article
  3. 3

    Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice by Cogram, Patricia, Alkon, Daniel L., Crockford, David, Deacon, Robert M. J., Hurley, Michael J., Altimiras, Francisco, Sun, Miao-Kun, Tranfaglia, Michael

    Published in Scientific reports (22-10-2020)
    “…Fragile X syndrome (FXS), an X-chromosome linked intellectual disability, is the leading monogenetic cause of autism spectrum disorder (ASD), a…”
    Get full text
    Journal Article
  4. 4

    Neuroprotective role for RORA in Parkinson’s disease revealed by analysis of post-mortem brain and a dopaminergic cell line by Al-Zaid, Felwah S., Hurley, Michael J., Dexter, David T., Gillies, Glenda E.

    Published in NPJ Parkinson's Disease (27-07-2023)
    “…Parkinson’s disease (PD) is almost twice as prevalent in men, which has largely been attributed to neuroprotective effect of oestradiol in women. RORA…”
    Get full text
    Journal Article
  5. 5

    Enhanced allele-specific PCR discrimination in SNP genotyping using 3′ locked nucleic acid (LNA) primers by Latorra, David, Campbell, Krista, Wolter, Andreas, Hurley, J. Michael

    Published in Human mutation (01-07-2003)
    “…The specificity and reliability of locked nucleic acid (LNA) substitution at the 3′ position of allele‐specific PCR (AS‐PCR) primers for SNP detection was…”
    Get full text
    Journal Article
  6. 6

    Microbiome alterations are associated with apolipoprotein E mutation in Octodon degus and humans with Alzheimer’s disease by Zampieri, Guido, Cabrol, Léa, Urra, Claudio, Castro-Nallar, Eduardo, Schwob, Guillaume, Cleary, David, Angione, Claudio, Deacon, Robert M.J., Hurley, Michael J., Cogram, Patricia

    Published in iScience (16-08-2024)
    “…Gut microbiome dysbiosis is linked to many neurological disorders including Alzheimer’s disease (AD). A major risk factor for AD is polymorphism in the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Controlling the misuse of cobalt in horses by Ho, Emmie N. M., Chan, George H. M., Wan, Terence S. M., Curl, Peter, Riggs, Christopher M., Hurley, Michael J., Sykes, David

    Published in Drug testing and analysis (01-01-2015)
    “…Cobalt is a well‐established inducer of hypoxia‐like responses, which can cause gene modulation at the hypoxia inducible factor pathway to induce…”
    Get full text
    Journal Article
  9. 9

    Bile acids and neurological disease by Hurley, Michael J., Bates, Rachel, Macnaughtan, Jane, Schapira, Anthony H.V.

    Published in Pharmacology & therapeutics (Oxford) (01-12-2022)
    “…This review will focus on how bile acids are being used in clinical trials to treat neurological diseases due to their central involvement with the…”
    Get full text
    Journal Article
  10. 10

    Design considerations and effects of LNA in PCR primers by Latorra, David, Arar, Khalil, Michael Hurley, J

    Published in Molecular and cellular probes (01-10-2003)
    “…The effects of comprehensive LNA substitution in PCR primers for amplification of human genomic DNA targets are presented in this report. Previous research…”
    Get full text
    Journal Article
  11. 11

    Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome mice by Hurley, Michael J, Deacon, Robert M J, Chan, A W Edith, Baker, David, Selwood, David L, Cogram, Patricia

    Published in Brain (London, England : 1878) (29-03-2022)
    “…Fragile X syndrome is the most common inherited intellectual disability and mono-genetic cause of autism spectrum disorder. It is a neurodevelopmental…”
    Get full text
    Journal Article
  12. 12

    The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases by Hurley, Michael J., Deacon, Robert M.J., Beyer, Katrin, Ioannou, Elena, Ibáñez, Agustin, Teeling, Jessica L., Cogram, Patricia

    Published in Pharmacology & therapeutics (Oxford) (01-08-2018)
    “…Alzheimer's disease (AD) is a multifactorial progressive neurodegenerative disease. Despite decades of research, no disease modifying therapy is available and…”
    Get full text
    Journal Article
  13. 13

    Voltage-gated calcium channels and Parkinson's disease by Hurley, Michael J, Dexter, David T

    Published in Pharmacology & therapeutics (Oxford) (01-03-2012)
    “…A complex interaction of environmental, genetic and epigenetic factors combine with ageing to cause the most prevalent of movement disorders Parkinson's…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Sampling Almonds for Aflatoxin, Part I: Estimation of Uncertainty Associated with Sampling, Sample Preparation, and Analysis by Whitaker, T.B, Slate, A.B, Jacobs, M, Hurley, J.M, Giesbrecht, F.G

    Published in Journal of AOAC International (01-07-2006)
    “…Domestic and international regulatory limits have been established for aflatoxin in almonds and other tree nuts. It is difficult to obtain an accurate and…”
    Get full text
    Journal Article
  16. 16

    NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome by Deacon, Robert M. J., Glass, Larry, Snape, Mike, Hurley, Michael J., Altimiras, Francisco J., Biekofsky, Rodolfo R., Cogram, Patricia

    Published in Neuromolecular medicine (01-03-2015)
    “…Fragile X syndrome (FXS) is the most common form of inherited intellectual disability. Previous studies have implicated mGlu5 in the pathogenesis of the…”
    Get full text
    Journal Article
  17. 17

    Calcium CaV1 Channel Subtype mRNA Expression in Parkinson’s Disease Examined by In Situ Hybridization by Hurley, Michael J., Gentleman, Steve M., Dexter, David T.

    Published in Journal of molecular neuroscience (01-03-2015)
    “…The factors which make some neurons vulnerable to neurodegeneration in Parkinson’s disease while others remain resistant are not fully understood. Studies in…”
    Get full text
    Journal Article
  18. 18

    α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept study by Hurley, Michael J, Menozzi, Elisa, Koletsi, Sofia, Bates, Rachel, Gegg, Matthew E, Chau, Kai-Yin, Blottière, Hervé M, Macnaughtan, Jane, Schapira, Anthony H V

    Published in Brain communications (01-11-2023)
    “…Abstract Caudo-rostral migration of pathological forms of α-synuclein from the gut to the brain is proposed as an early feature in Parkinson’s disease…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson’s Disease by Hurley, Michael J., Durrenberger, Pascal F., Gentleman, Steve M., Walls, Andrew F., Dexter, David T.

    Published in Journal of molecular neuroscience (01-09-2015)
    “…Neuroinflammation is thought to contribute to cell death in neurodegenerative disorders, but the factors involved in the inflammatory process are not…”
    Get full text
    Journal Article